国家: 爱尔兰
语言: 英文
来源: HPRA (Health Products Regulatory Authority)
Tiotropium bromide
Merit Pharmaceuticals Limited
R03BB; R03BB04
Tiotropium bromide
18 microgram(s)
Inhalation powder, hard capsule
Anticholinergics; tiotropium bromide
2012-08-17
SPIRIVA ® 18 MICROGRAM, INHALATION POWDER, HARD CAPSULE tiotropium This product is known by the above name but will be referred to as Spiriva 18 microgram throughout this: PACKAGE LEAFLET INFORMATION FOR THE USER WHAT IS IN THIS LEAFLET: 1) What Spiriva 18 microgram is and what it is used for 2) What you need to know before you take Spiriva 18 microgram 3) How to take Spiriva 18 microgram 4) Possible side effects 5) How to store Spiriva 18 microgram 6) Contents of the pack and other information 1) WHAT SPIRIVA 18 MICROGRAM IS AND WHAT IT IS USED FOR Spiriva 18 microgram helps people who have chronic obstructive pulmonary disease (COPD) to breathe more easily. COPD is a chronic lung disease that causes shortness of breath and coughing. The term COPD is associated with the conditions chronic bronchitis and emphysema. As COPD is a chronic disease you should take Spiriva 18 microgram every day and not only when you have breathing problems or other symptoms of COPD. Spiriva 18 microgram is a long-acting bronchodilator that helps to open your airways and makes it easier to get air in and out of the lungs. Regular use of Spiriva 18 microgram can also help you when you have on-going shortness of breath related to your disease and will help you to minimise the effects of the disease on your everyday life. It also helps you to be active longer. Daily use of Spiriva 18 microgram will also help to prevent sudden, short-term worsening of your COPD symptoms which may last for several days. The effect of this medicine lasts for 24 hours, so you only need to take it once a day. For correct dosing of Spiriva 18 microgram please see section 3. How to take Spiriva 18 microgram and the instructions for use provided on the other side of the leaflet. 2) WHAT YOU NEED TO KNOW BEFORE YOU TAKE SPIRIVA 18 MICROGRAM PLEASE READ THE FOLLOWING QUESTIONS CAREFULLY. If you can answer any of these questions with “YES” please discuss this with your doctor BEFORE taking Spiriva 18 microgram • are you allergic to tiotropium, atropine or sim 阅读完整的文件
Health Products Regulatory Authority 21 May 2021 CRN00C2S0 Page 1 of 12 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Spiriva 18 microgram inhalation powder, hard capsule 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains 22.5 microgram tiotropium bromide monohydrate equivalent to 18 microgram tiotropium. The delivered dose (the dose that leaves the mouthpiece of the HandiHaler device) is 10 microgram tiotropium. Excipient: Lactose monohydrate For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Inhalation powder, hard capsule. _Product imported from the UK and France:_ Light green hard capsules with the product code TI 01 and company logo printed on the capsule. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Tiotropium is indicated as a maintenance bronchodilator treatment to relieve symptoms of patients with chronic obstructive pulmonary disease (COPD). 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology: The medicinal product is intended for inhalation use only. The recommended dosage of tiotropium bromide is inhalation of the contents of one capsule once daily with the HandiHaler device at the same time of day. The recommended dose should not be exceeded. Tiotropium bromide capsules must not be swallowed. Tiotropium bromide should only be inhaled with the HandiHaler device. Special populations: Geriatric patients can use tiotropium bromide at the recommended dose. Renally impaired patients can use tiotropium bromide at the recommended dose. For patients with moderate to severe impairment (creatinine clearance ≤ 50 ml/min) see section 4.4 and section 5.2. Hepatically impaired patients can use tiotropium bromide at the recommended dose (see section 5.2). Paediatric population: There is no relevant use in the paediatric population (below 18 years) in the indication stated under section 4.1. Method of administration: To ensure proper administration of the medicinal product the patient should be trained how to use the inhaler by the physician or by other hea 阅读完整的文件